Cerus Corporation (NASDAQ:CERS) went down by -1.60% from its latest closing price compared to the recent 1-year high of $7.94. The company’s stock price has collected 4.41% of gains in the last five trading sessions. Press Release reported on 09/28/20 that Cerus Corporation Announces Schedule of Presentations at the AABB 2020 Virtual Annual Meeting
Is It Worth Investing in Cerus Corporation (NASDAQ :CERS) Right Now?
Plus, the 36-month beta value for CERS is at 1.14. Opinions of the stock are interesting as 4 analysts out of 4 who provided ratings for Cerus Corporation declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $9.13, which is $2.97 above the current price. CERS currently public float of 162.58M and currently shorts hold a 6.73% ratio of that float. Today, the average trading volume of CERS was 1.56M shares.
CERS’s Market Performance
CERS stocks went up by 4.41% for the week, with a monthly drop of -2.07% and a quarterly performance of -8.88%, while its annual performance rate touched 29.14%. The volatility ratio for the week stands at 3.73% while the volatility levels for the past 30 days are set at 4.12% for Cerus Corporation. The simple moving average for the period of the last 20 days is 0.09% for CERS stocks with a simple moving average of 10.72% for the last 200 days.
Analysts’ Opinion of CERS
Many brokerage firms have already submitted their reports for CERS stocks, with Cantor Fitzgerald repeating the rating for CERS by listing it as a “Overweight.” The predicted price for CERS in the upcoming period, according to Cantor Fitzgerald is $9 based on the research report published on June 16th of the current year 2020.
BTIG Research, on the other hand, stated in their research note that they expect to see CERS reach a price target of $7. The rating they have provided for CERS stocks is “Buy” according to the report published on February 26th, 2020.
BTIG Research gave a rating of “Buy” to CERS, setting the target price at $7 in the report published on November 13th of the previous year.
CERS Trading at -6.41% from the 50-Day Moving Average
After a stumble in the market that brought CERS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -22.42% of loss for the given period.
Volatility was left at 4.12%, however, over the last 30 days, the volatility rate increased by 3.73%, as shares sank -1.44% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -7.78% lower at present.
During the last 5 trading sessions, CERS rose by +4.41%, which changed the moving average for the period of 200-days by +55.56% in comparison to the 20-day moving average, which settled at $6.15. In addition, Cerus Corporation saw 45.97% in overturn over a single year, with a tendency to cut further gains.
Reports are indicating that there were more than several insider trading activities at CERS starting from ANDERSON TIMOTHY B, who sale 16,008 shares at the price of $7.90 back on Aug 24. After this action, ANDERSON TIMOTHY B now owns 210,101 shares of Cerus Corporation, valued at $126,463 using the latest closing price.
Benjamin Richard J, the Chief Medical Officer of Cerus Corporation, sale 100,000 shares at $7.90 during a trade that took place back on Aug 24, which means that Benjamin Richard J is holding 41,763 shares at $790,000 based on the most recent closing price.
Stock Fundamentals for CERS
Current profitability levels for the company are sitting at:
- -70.62 for the present operating margin
- +62.02 for the gross margin
The net margin for Cerus Corporation stands at -75.97. The total capital return value is set at -56.15, while invested capital returns managed to touch -64.36. Equity return is now at value -76.80, with -34.80 for asset returns.
Based on Cerus Corporation (CERS), the company’s capital structure generated 112.97 points at debt to equity in total, while total debt to capital is 53.04. Total debt to assets is 38.93, with long-term debt to equity ratio resting at 101.35. Finally, the long-term debt to capital ratio is 47.59.
When we switch over and look at the enterrpise to sales, we see a ratio of 6.07, with the company’s debt to enterprise value settled at 0.11. The receivables turnover for the company is 6.42 and the total asset turnover is 0.57. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.55.